Enlightify Faces NYSE Compliance Issue with $1 Minimum Share Price

Enlightify has received a non-compliance notice from the NYSE for trading below the $1 minimum average closing price over 30 days. The company has six months to regain compliance and avoid delisting, but shares remain listed and tradable during this time. Enlightify has notified the NYSE of its intent to cure the price deficiency, causing a 9.6% increase in ENFY shares post-market on Wednesday.

Enlightify Inc. (NYSE: ENFY) has received a non-compliance notice from the New York Stock Exchange (NYSE) regarding its minimum share price requirement. The company's stock has traded below $1.00 for a 30-trading-day average, which is the minimum average share price required for continued listing under NYSE rules. Enlightify has six months (with possible extension) to regain compliance and avoid delisting Enlightify notified by NYSE of non-compliance with $1 minimum share price rule^[1].

Enlightify has notified the NYSE of its intent to cure the price deficiency, which has led to a 9.6% increase in ENFY shares post-market on Wednesday. The company's stock continues to be listed and traded on the NYSE, subject to the company's compliance with other NYSE continued listing requirements. The NYSE notification does not affect the company's business operations or its Securities and Exchange Commission (SEC) reporting obligations Enlightify Inc. Notifies New York Stock Exchange of Intent to Cure Price Deficiency^[2].

Enlightify produces and distributes humic acid-based compound fertilizers and other agricultural products through its wholly owned subsidiaries. In 2023, the company started to purchase digital asset mining machines and established Antaeus Tech Inc. to mine digital assets. The company's actual results may differ materially from those anticipated due to various risk factors, including economic conditions, competition, interest rate fluctuations, and the impact of the global COVID-19 pandemic Enlightify Inc. Notifies New York Stock Exchange of Intent to Cure Price Deficiency^[2].

Enlightify Inc. is committed to addressing the non-compliance issue and regaining compliance with NYSE listing standards to ensure the continued listing of its stock. Investors and financial professionals should monitor the company's progress and any updates regarding its compliance efforts.